Transduction and oncolytic profile of a potent replication-competent adenovirus 11p vector (RCAD11pGFP) in colon carcinoma cells

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Silver, Jim ^a   Mei, Ya Fang ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CARCINOEMBRYONIC ANTIGEN; GREEN FLUORESCENT PROTEIN; MEMBRANE COFACTOR PROTEIN; REPLICATION COMPETENT ADENOVIRUS 11P VECTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOMA CELL; CELL PROLIFERATION; CELL STRAIN HT29; COLON CARCINOMA; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SOLID TUMOR; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM; VIRUS STRAIN; ADENOVIRUS; COLON TUMOR; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; METABOLISM; METHODOLOGY; PHYSIOLOGY; TUMOR CELL LINE; VIRUS REPLICATION;

HUMAN ADENOVIRUS TYPE 11; HUMAN ADENOVIRUS TYPE 5; MUS;

ADENOVIRIDAE; CELL LINE, TUMOR; COLONIC NEOPLASMS; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HT29 CELLS; HUMANS; TRANSDUCTION, GENETIC; VIRUS REPLICATION;

EID: 79953043411     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017532     Document Type: Article

References (42)

1. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
2. Tomlinson I, Ilyas M, Novelli M, (1997) Molecular genetics of colon cancer. Cancer Metastasis Rev 16: 67-79.
3. Holterman L, Vogels R, van der Vlugt R, Sieuwerts M, Grimbergen J, et al. (2004) Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5. J Virol 78: 13207-13215.
4. Wilson JM, (1996) Adenoviruses as gene-delivery vehicles. N Engl J Med 334: 1185-1187.
5. Chung-Faye GA, Kerr DJ, (2000) ABC of colorectal cancer: Innovative treatment for colon cancer. BMJ 321: 1397-1399.
6. Wildner O, Blaese RM, Morris JC, (1999) Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpes simplex virus-thymidine kinase. Cancer Res 59: 410-413.
7. Zwacka RM, Dunlop MG, (1998) Gene therapy for colon cancer. Hematol Oncol Clin North Am 12: 595-615.
8. Vogels R, Zuijdgeest D, van Rijnsoever R, Hartkoorn E, Damen I, et al. (2003) Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity. J Virol 77: 8263-8271.
9. Mei YF, Wadell G, (1993) Hemagglutination properties and nucleotide sequence analysis of the fiber gene of adenovirus genome types 11p and 11a. Virology 194: 453-462.
10. Mei YF, Lindman K, Wadell G, (2002) Human adenoviruses of subgenera B, C, and E with various tropisms differ in both binding to and replication in the epithelial A549 and 293 cells. Virology 295: 30-43.
11. Short JJ, Vasu C, Holterman MJ, Curiel DT, Pereboev A, (2006) Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptors. Virus Res 122: 144-153.
12. Fleischli C, Sirena D, Lesage G, Havenga MJ, Cattaneo R, et al. (2007) Species B adenovirus serotypes 3, 7, 11 and 35 share similar binding sites on the membrane cofactor protein CD46 receptor. J Gen Virol 88: 2925-2934.
13. Waddington SN, McVey JH, Bhella D, Parker AL, Barker K, et al. (2008) Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132: 397-409.
14. Kim M, Sumerel LA, Belousova N, Lyons GR, Carey DE, et al. (2003) The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells. Br J Cancer 88: 1411-1416.
15. Anderson BD, Nakamura T, Russell SJ, Peng KW, (2004) High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus. Cancer Res 64: 4919-4926.
16. Wang H, Li ZY, Liu Y, Persson J, Beyer I, et al. (2011) Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. Nat Med 17: 96-104.
17. Stevenson SC, Rollence M, Marshall-Neff J, McClelland A, (1997) Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein. J Virol 71: 4782-4790.
18. Douglas JT, Miller CR, Kim M, Dmitriev I, Mikheeva G, et al. (1999) A system for the propagation of adenoviral vectors with genetically modified receptor specificities. Nat Biotechnol 17: 470-475.
19. Rea D, Havenga MJ, van Den Assem M, Sutmuller RP, Lemckert A, et al. (2001) Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells. J Immunol 166: 5236-5244.
20. Kawakami Y, Li H, Lam JT, Krasnykh V, Curiel DT, et al. (2003) Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replication. Cancer Res 63: 1262-1269.
21. Stone D, Ni S, Li ZY, Gaggar A, DiPaolo N, et al. (2005) Development and assessment of human adenovirus type 11 as a gene transfer vector. J Virol 79: 5090-5104.
22. Brouwer E, Havenga MJ, Ophorst O, de Leeuw B, Gijsbers L, et al. (2007) Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients. Cancer Gene Ther 14: 211-219.
23. Sirena D, Ruzsics Z, Schaffner W, Greber UF, Hemmi S, (2005) The nucleotide sequence and a first generation gene transfer vector of species B human adenovirus serotype 3. Virology 343: 283-298.
24. Tomko RP, Xu R, Philipson L, (1997) HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A 94: 3352-3356.
25. Segerman A, Atkinson JP, Marttila M, Dennerquist V, Wadell G, et al. (2003) Adenovirus type 11 uses CD46 as a cellular receptor. J Virol 77: 9183-9191.
26. Gaggar A, Shayakhmetov DM, Lieber A, (2003) CD46 is a cellular receptor for group B adenoviruses. Nat Med 9: 1408-1412.
27. Bakalakos EA, Burak WE Jr, Young DC, Martin EW Jr, (1999) Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases? Am J Surg 177: 2-6.
28. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR, (1993) Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73: 309-319.
29. Segerman A, Arnberg N, Erikson A, Lindman K, Wadell G, (2003) There are two different species B adenovirus receptors: sBAR, common to species B1 and B2 adenoviruses, and sB2AR, exclusively used by species B2 adenoviruses. J Virol 77: 1157-1162.
30. Nemerow GR, Stewart PL, (1999) Role of alpha(v) integrins in adenovirus cell entry and gene delivery. Microbiol Mol Biol Rev 63: 725-734.
31. Blumenthal RD, Hansen HJ, Goldenberg DM, (2005) Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen). Cancer Res 65: 8809-8817.
32. Velcich A, Palumbo L, Jarry A, Laboisse C, Racevskis J, et al. (1995) Patterns of expression of lineage-specific markers during the in vitro-induced differentiation of HT29 colon carcinoma cells. Cell Growth Differ 6: 749-757.
33. Wang J, Gray-Owen SD, Knorre A, Meyer TF, Dehio C, (1998) Opa binding to cellular CD66 receptors mediates the transcellular traversal of Neisseria gonorrhoeae across polarized T84 epithelial cell monolayers. Mol Microbiol 30: 657-671.
34. Huarte E, Larrea E, Hernandez-Alcoceba R, Alfaro C, Murillo O, et al. (2006) Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication. Mol Ther 14: 129-138.
35. Hoffmann D, Wildner O, (2006) Restriction of adenoviral replication to the transcriptional intersection of two different promoters for colorectal and pancreatic cancer treatment. Mol Cancer Ther 5: 374-381.
36. Sandberg L, Papareddy P, Silver J, Bergh A, Mei YF, (2009) Replication-competent Ad11p vector (RCAd11p) efficiently transduces and replicates in hormone-refractory metastatic prostate cancer cells. Hum Gene Ther 20: 361-373.
37. Cawkwell L, Lewis FA, Quirke P, (1994) Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br J Cancer 70: 813-818.
38. Wang Y, Gangeswaran R, Zhao X, Wang P, Tysome J, et al. (2009) CEACAM6 attenuates adenovirus infection by antagonizing viral trafficking in cancer cells. J Clin Invest 119: 1604-1615.
39. Mei YF, Lindman K, Wadell G, (1998) Two closely related adenovirus genome types with kidney or respiratory tract tropism differ in their binding to epithelial cells of various origins. Virology 240: 254-266.
40. Skog J, Mei YF, Wadell G, (2002) Human adenovirus serotypes 4p and 11p are efficiently expressed in cell lines of neural tumour origin. J Gen Virol 83: 1299-1309.
41. Chartier C, Degryse E, Gantzer M, Dieterle A, Pavirani A, et al. (1996) Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol 70: 4805-4810.
42. Hammarstrom S, (1999) The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 9: 67-81.